Cargando…
Anaesthetic Management of a Patient With Immune-Mediated Necrotizing Muscle Disease With the Use of a Novel Ultrashort-Acting Benzodiazepine, Remimazolam: A Case Report
We reported the anesthetic management of remimazolam, a novel ultra-short-acting benzodiazepine, for a 21-month-old female with immune-mediated necrotizing myopathy (IMNM). Remimazolam has a similar chemical structure to midazolam but possesses a unique side chain that reduces its propensity to accu...
Autores principales: | Ogino, Hitoshi, Sugiyama, Daisuke, Ueda, Kenichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168013/ https://www.ncbi.nlm.nih.gov/pubmed/37182089 http://dx.doi.org/10.7759/cureus.37326 |
Ejemplares similares
-
Novel ultrashort-acting benzodiazepine remimazolam lowers shivering threshold in rabbits
por: Muroya, Kenji, et al.
Publicado: (2022) -
Two Cases of Inadequate Response to Remimazolam
por: Kitaura, Atsuhiro, et al.
Publicado: (2023) -
Monitored Anesthesia Care Under a Combination of Low-Dose Remimazolam Infusion and Flumazenil Antagonism: A Case Report
por: Kamata, Kotoe, et al.
Publicado: (2023) -
A Case of Decreased Amplitude in Motor Evoked Potentials Under Remimazolam Anesthesia
por: Aratani, Yuichi, et al.
Publicado: (2022) -
Invasive Metastatic Well-Differentiated Liposarcoma to the Heart, Found in Intraoperative Transesophageal Echocardiography
por: Kawakami, Junshi, et al.
Publicado: (2022)